Hematology / Medical Oncology Fellowship Training Program
Mission
The mission of the Hematology/Medical Oncology Fellowship Training Program at the NYU School of Medicine is to train and mentor academic physician-scientists and clinicians in the discipline of Hematology and Medical Oncology leading to American Board of Internal Medicine eligibility in both subspecialties of Hematology and Medical Oncology.
Overview
The Hematology/Medical Oncology Fellowship Training Program of the New York University School of Medicine is an ACGME-accredited combined three-year training program supported by two T32 grants for training in hematology and oncology. The NYU curriculum is designed to provide thorough exposure to the clinical practice of hematology and medical oncology while providing an intensive educational content.
The Division of Oncology is a major component of the NYU Cancer Institute and its NCI-designated Cancer Center. Our fellows benefit from the role the Division play in the administration, clinical research and patient care of the Cancer Institute.
Goals and Objectives
The goals and objectives for the Hematology/Medical Oncology Fellowship Training Program are:
- Pathophysiologic Principles – fellows will demonstrate the understanding of general principles common to Hematology and Medical Oncology.
- Ambulatory and Inpatient care of Hematology/Oncology Patients – fellows will develop interpersonal skills with patients and health care providers; fellows will function effectively as a member of an interdisciplinary health care team; fellows will gather pertinent information to assist them in caring for their patients; fellows will document patient encounters effectively; fellows will document with clarity medication regimens, including chemotherapy, antibiotics, blood products, growth factors prescribed and/or administered; fellows will plan and coordinate follow-up care; and the fellows will demonstrate the ability to act as patients’ advocate.
- Consultative Medicine – fellows will request effective consultations; fellows will deliver effective consultations.
- Fellows will demonstrate proficiency in the follows areas: interpersonal and communication skills; humanistic behaviors; medical ethics; cancer prevention and screening; technical and other skills (develop competence or expertise in the performance and interpretation of Hematology and Medical Oncology); practice-based learning and improvement; professionalism; systems-based practice and quality assessment.
Clinical and Research Training
The Division of Medical Oncology works closely with the Division of Hematology to provide our fellows with an outstanding education in hematological and solid tumors. They are exposed to a wide spectrum of medical cases, patients and technologies through the combined yet distinct clinical resources of the NYU Medical Center, including Tisch Hospital, Bellevue Hospital Center, Veterans Affairs Hospital and the Hospital for Joint Diseases.
In order to enhance the fellows training and provide a greater mix of clinical consultation, and expand faculty resources, the fellows have an elective of Allogenic Bone Marrow Transplant training at Memorial Sloan-Kettering Cancer Center.
The goal of the first year of training program is to provide a creative clinical environment for the fellows to develop skills and experience in the comprehensive care of cancer patients and in the diagnosis and management of hematologic diseases. The fellows are assigned to both inpatient and out patient clinical rotations.
In the second year of the training program, the fellows will continue on clinical rotations with increased level of responsibilities. Having successfully completed the first year they will supervise house staff and junior fellows in performing procedures such as bone marrow aspiration and biopsy, administration of intrathecal chemotherapy and initial evaluation of patients. They will supervise patients in the General Clinical Research Center (GCRC) and communicate with the Principal Investigators. They will have on-going ambulatory clinic experience. They will have the opportunity to meet with different scientific investigators to pick a mentor and develop a research project. They will be able to attend clinical selectives in specific sub-divisions of Medical Oncology and will present cases at multidisciplinary tumor boards.
The third year of the training program is devoted primarily to research. The fellows will continue in their continuity clinics. They will serve as a clinical resource for the junior fellows to discuss patients during the evaluation process prior to presentation to the Attending physician and to continue to move toward independent clinical decision making. All fellows are expected to give scholarly presentations at internal and national meetings. For promising research candidates, an additional fourth year of laboratory training may be provided. The fellows may also pursue by pre-arrangement elective periods in Palliative Care and other areas of Oncology.
Core Curriculum and Conferences
A. Required Core Conferences:
- Hematology Core Curriculum Conference – presented materials are available with the program coordinator for review Attendance will be taken and 70% attendance required for promotion
- Hematology Multidisciplinary Patient Management Conference and M&M
Attendance will be taken and 70% attendance required for promotion - Hematology/Oncology Research Seminar – weekly attendance encouraged; once a month attendance mandatory; attendance will be taken
- Hematology Journal Club weekly attendance encouraged; once a month attendance mandatory; attendance will be taken
B. Other required conferences:
- Hematopathology Conference
- Hematology/Oncology Clinical Rounds
C. CONFERENCE SCHEDULE
Monday 8:00-9:00 AM
Hematology Core Curriculum Lecture - Lectures covering core curriculum of hematology.
Tuesday, 8:00-9:00 AM
Hematology Journal Club - Presentation of 2 articles from the current literature with relevance to hematology, hematologic oncology, hemostasis and coagulation, and molecular biology by hematology fellows and attendings. Fellows are encouraged to present papers from scientific journals with a translational topic. Such journals include: Nature Medicine, Nature, Science, Cell, JCI, JBC, JEM, Cancer Research, and Blood—rather than a clinical treatment paper. The purpose of journal club is not only to report on interesting new information relating to Hematology/Oncology but also to get you into the mode of reading scientific journals. This is the true way to become a scientifically sophisticated physician-scientist. Articles selected for presentation must be approved by Drs. Hymes, Karpatkin, Gardner, or Green. See attached schedule for assignments.
Tuesday, 9:00-9:40 AM
Bellevue Clinic Patient Management and Evidence Based Hematology Conference
Discussion of the evidence regarding a question raised in the prior clinic; Level of evidence and a salient presentation of the literature.
Wednesday 8:00 AM
Medicine Grand Rounds – (Sept-June)
Wednesday 11:00 AM (alternate weeks)
Bellevue Heme/Onc ward pathology conference - Inpatient cases discussed.
Wednesday
Wednesday 4:30 PM
NYU Cancer Institute Grand Rounds - (Sept-June)
Thursday, 8:15-9:30 AM
Hematology Management Conference - Multidisciplinary Tumor Board and Performance Review Conference. Discussion of new and management problem patients at all three hospitals. The patient is presented in detail. Fellows will prepare brief reports about controversial topics or evidence regarding treatment decisions that arise during the discussion. Review of practice, adherence to guidelines and performance improvement will be discussed. Please bring pathology peripheral smears and bone marrow slides as well as X-rays for review. The Hematology Management Conference is moderated by Dr. Bruce Raphael (212-731-5185).
Friday, 8:00-9:00 AM
Hematopathology Conference - Review of interesting and important bone marrow, lymph node, and other biopsies of TH inpatients and outpatients. Conference will be held at Tisch Hospital exclusively. Bellevue cases for discussion should be identified to Dr. Yee (212-562-6584), so they can be sent over.
Friday, 9:00-10:00 AM (every other week)
Transplant Conference - Required for the Tisch fellow and highly recommended for others; Discussion of patients undergoing transplant; led by Dr. Perry Cook (212-731-5184).
Friday, 1:00-2:00 PM*
Hematology/Oncology Research Seminar - Weekly seminars from distinguished investigators from outside the institution. “Cutting edge” research on topics of hematologic/oncologic interest. (*September through June)
Friday, 2:00-3:00 PM.*
(*During July, Clinical Rounds will be held from 1:00 to 2:00 PM instead of 2:00 to 3:00 PM.)
Hematology/Oncology Clinical Rounds - Presentations by NYU attending staff and fellows. Research in progress or topics of clinical interest are presented in depth. See attached schedule for assignments. Dr. Karpatkin will supervise the fellows’ preparation of these talks.
Please contact Dr. S. Karpatkin at least 4 weeks prior to the scheduled presentation via email at karpas01@nyumc.org or at 212-263-5609.